338 related articles for article (PubMed ID: 16757203)
1. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies.
Dodd RL; Slevin NJ
Oral Oncol; 2006 Sep; 42(8):759-69. PubMed ID: 16757203
[TBL] [Abstract][Full Text] [Related]
2. Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study.
Hotte SJ; Winquist EW; Lamont E; MacKenzie M; Vokes E; Chen EX; Brown S; Pond GR; Murgo A; Siu LL
J Clin Oncol; 2005 Jan; 23(3):585-90. PubMed ID: 15659505
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: a review.
Papaspyrou G; Hoch S; Rinaldo A; Rodrigo JP; Takes RP; van Herpen C; Werner JA; Ferlito A
Head Neck; 2011 Jun; 33(6):905-11. PubMed ID: 20652885
[TBL] [Abstract][Full Text] [Related]
4. Epirubicin, cisplatin and protracted venous infusion 5-Fluorouracil chemotherapy for advanced salivary adenoid cystic carcinoma.
Ross PJ; Teoh EM; A'hern RP; Rhys-Evans PH; Harrington KJ; Nutting CM; Gore ME
Clin Oncol (R Coll Radiol); 2009 May; 21(4):311-4. PubMed ID: 19201585
[TBL] [Abstract][Full Text] [Related]
5. Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: report of two successfully treated cases.
Alcedo JC; Fábrega JM; Arosemena JR; Urrutia A
Head Neck; 2004 Sep; 26(9):829-31. PubMed ID: 15350030
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands.
Pfeffer MR; Talmi Y; Catane R; Symon Z; Yosepovitch A; Levitt M
Oral Oncol; 2007 Jan; 43(1):33-6. PubMed ID: 16757202
[TBL] [Abstract][Full Text] [Related]
7. As2O3 may be a treatment option for adenoid cystic carcinoma of salivary gland.
Fu ZC; Zhang B; Fu ZJ
Med Hypotheses; 2010 Dec; 75(6):490-1. PubMed ID: 20656411
[TBL] [Abstract][Full Text] [Related]
8. Microdissection genotyping analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
Tse DT; Finkelstein SD; Benedetto P; Dubovy S; Schiffman J; Feuer WJ
Am J Ophthalmol; 2006 Jan; 141(1):54-61. PubMed ID: 16386976
[TBL] [Abstract][Full Text] [Related]
9. Update and perspectives on non-surgical treatment of salivary gland malignancies.
Airoldi M; Cortesina G; Giordano C; Pedani F; Cavalot A; Marcato P; Beatrice F; Bumma C
Acta Otorhinolaryngol Ital; 2003 Oct; 23(5):368-76. PubMed ID: 15108487
[TBL] [Abstract][Full Text] [Related]
10. Management of adenoid cystic carcinoma of minor salivary glands.
Triantafillidou K; Dimitrakopoulos J; Iordanidis F; Koufogiannis D
J Oral Maxillofac Surg; 2006 Jul; 64(7):1114-20. PubMed ID: 16781345
[TBL] [Abstract][Full Text] [Related]
11. Bilateral intraosseous adenoid cystic carcinoma of the mandible: report of a case with lung metastases at first clinical presentation.
Capodiferro S; Scully C; Macaita MG; Lo Muzio L; Favia G; Mairoano E
Oral Dis; 2005 Mar; 11(2):109-12. PubMed ID: 15752085
[TBL] [Abstract][Full Text] [Related]
12. Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas).
Marchiò C; Weigelt B; Reis-Filho JS
J Clin Pathol; 2010 Mar; 63(3):220-8. PubMed ID: 20203221
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy with paclitaxel for lung metastases of cystic adenoid carcinoma. A case report and review of the literature].
Perrot E; Davy N; Poubeau P; Arvin-Berod C
Rev Pneumol Clin; 2003 Dec; 59(6):371-4. PubMed ID: 14745344
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin.
Vered M; Braunstein E; Buchner A
Head Neck; 2002 Jul; 24(7):632-6. PubMed ID: 12112535
[TBL] [Abstract][Full Text] [Related]
15. Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model.
Younes MN; Park YW; Yazici YD; Gu M; Santillan AA; Nong X; Kim S; Jasser SA; El-Naggar AK; Myers JN
Mol Cancer Ther; 2006 Nov; 5(11):2696-705. PubMed ID: 17121916
[TBL] [Abstract][Full Text] [Related]
16. Salivary gland malignancies: the role for chemotherapy and molecular targeted agents.
Surakanti SG; Agulnik M
Semin Oncol; 2008 Jun; 35(3):309-19. PubMed ID: 18544445
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of the combination of 5 fluorouracil, adriamycin and cisplatin (FAP protocol) in the treatment of metastatic cylindroma. Apropos of a case with review of the literature].
Farhat F; Kattan J; Culine S; Bekradda M; Droz JP
Bull Cancer; 1994 Jan; 81(1):47-50. PubMed ID: 7949584
[TBL] [Abstract][Full Text] [Related]
18. Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma.
Patel KJ; Pambuccian SE; Ondrey FG; Adams GL; Gaffney PM
Oral Oncol; 2006 Nov; 42(10):994-1004. PubMed ID: 16762588
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the treatment of salivary gland cancers: emphasis on molecular targeted therapy.
Milano A; Longo F; Basile M; Iaffaioli RV; Caponigro F
Oral Oncol; 2007 Sep; 43(8):729-34. PubMed ID: 17350323
[TBL] [Abstract][Full Text] [Related]
20. Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland.
Le Tourneau C; Razak AR; Levy C; Calugaru V; Galatoire O; Dendale R; Desjardins L; Gan HK
Br J Ophthalmol; 2011 Nov; 95(11):1483-9. PubMed ID: 21183517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
